Hostname: page-component-745bb68f8f-d8cs5 Total loading time: 0 Render date: 2025-01-08T12:15:33.488Z Has data issue: false hasContentIssue false
  • English
  • Français

Applying mucosal barrier injury laboratory-confirmed bloodstream infection criteria in patients with solid tumors and hematologic malignancies: A retrospective cohort study looking for the real source of infection

Published online by Cambridge University Press:  11 February 2022

Ana Carolina Puin da Silva Open the ORCID record for Ana Carolina Puin da Silva [Opens in a new window] ,
Michely Fernandes Vieira ,
Maristela Pinheiro Freire ,
Lumena Vaz ,
Patrícia Rodrigues Bonazzi ,
Karim Yaqub Ibrahim Open the ORCID record for Karim Yaqub Ibrahim [Opens in a new window] ,
Maria Del Pilar Esteves Diz Open the ORCID record for Maria Del Pilar Esteves Diz [Opens in a new window] ,
Paulo Marcelo Hoff Open the ORCID record for Paulo Marcelo Hoff [Opens in a new window] ,
Juliana Pereira  and
Vanderson Geraldo Rocha Open the ORCID record for Vanderson Geraldo Rocha [Opens in a new window]
...Show all authors
Ana Carolina Puin da Silva*
Affiliation:
Hospital Infection Control and Infectious Diseases Service, Instituto do Cancer do Estado de Sao Paulo, School of Medicine, University of São Paulo, Brazil
Michely Fernandes Vieira
Affiliation:
Hospital Infection Control and Infectious Diseases Service, Instituto do Cancer do Estado de Sao Paulo, School of Medicine, University of São Paulo, Brazil
Maristela Pinheiro Freire
Affiliation:
Hospital Infection Control and Infectious Diseases Service, Instituto do Cancer do Estado de Sao Paulo, School of Medicine, University of São Paulo, Brazil
Lumena Vaz
Affiliation:
Hospital Infection Control and Infectious Diseases Service, Instituto do Cancer do Estado de Sao Paulo, School of Medicine, University of São Paulo, Brazil
Patrícia Rodrigues Bonazzi
Affiliation:
Hospital Infection Control and Infectious Diseases Service, Instituto do Cancer do Estado de Sao Paulo, School of Medicine, University of São Paulo, Brazil
Karim Yaqub Ibrahim
Affiliation:
Hospital Infection Control and Infectious Diseases Service, Instituto do Cancer do Estado de Sao Paulo, School of Medicine, University of São Paulo, Brazil
Maria Del Pilar Esteves Diz
Affiliation:
Oncology Service, Instituto do Cancer do Estado de Sao Paulo, School of Medicine, University of São Paulo, Brazil
Paulo Marcelo Hoff
Affiliation:
Oncology Service, Instituto do Cancer do Estado de Sao Paulo, School of Medicine, University of São Paulo, Brazil
Juliana Pereira
Affiliation:
Hematology Service, Instituto do Cancer do Estado de Sao Paulo, School of Medicine, University of São Paulo, Brazil
Vanderson Geraldo Rocha
Affiliation:
Hematology Service, Instituto do Cancer do Estado de Sao Paulo, School of Medicine, University of São Paulo, Brazil
Edson Abdala
Affiliation:
Hospital Infection Control and Infectious Diseases Service, Instituto do Cancer do Estado de Sao Paulo, School of Medicine, University of São Paulo, Brazil Department of Infectious and Parasitic Diseases, School of Medicine, University of São Paulo, Brazil
*
Author for correspondence: A. C. P. Silva, E-mail: anacarolina_puin@yahoo.com
Get access Rights & Permissions [Opens in a new window]

Abstract

We evaluated the interference of the mucosal barrier injury (MBI) laboratory-confirmed bloodstream infection (MBI-LCBI) criteria on the central-line–associated bloodstream infection (CLABSI) incidence density, and the proportion of catheter-related bloodstream infections (CRBSIs) among those classified as MBI. We detected 339 CLABSIs: 15.0% were classified as MBI-LCBIs, and among these, 19.6% were classified as CRBSIs.

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 44 , Issue 2 , February 2023 , pp. 302 - 304
Check for updates
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Metzger, KE, Rucker, Y, Callaghan, M, et al. The burden of mucosal barrier injury laboratory-confirmed bloodstream infection among hematology, oncology, and stem cell transplant patients. Infect Control Hosp Epidemiol 2015;36:119–124.CrossRefGoogle ScholarPubMed
Device-associates module. Bloodstream infection event (central line-associated bloodstream infection and non-central line-associated bloodstream infection), 2016. Centers for Disease Control and Prevention website. https://www.cdc.gov/nhsn/pdfs/pscmanual/4psc_clabscurrent.pdf. Updated 2022. Accessed January 31, 2022.Google Scholar
Vaughan, AM, Ross, R, Gilman, MM, et al. Mucosal barrier injury central-line–associated bloodstream infections: what is the impact of standard prevention bundles? Infect Control Hosp Epidemiol 2017;38:1385–1387.CrossRefGoogle ScholarPubMed
Mermel, LA, Allon, M, Bouza, E, et al. IDSA Guidelines. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;49:1–45.CrossRefGoogle Scholar
ANVISA. Investigação e controle de bactérias multirresistentes, 2007. Agência Nacional de Vigilância Sanitária website. http://anvisa.gov.br/servicosaude/controle/reniss/manual%20_controle_bacterias.pdf, Published 2007. Accessed January 26, 2022.Google Scholar
NCCN guidelines. Prevention and treatment of cancer-related infections (version I.2018–December 1, 2017). National Comprehensive Cancer Network website. https://www.nccn.org/. Accessed January 26, 2022.Google Scholar
Islas-Muñoz, B, Volkow-Fernández, P, Ibanes-Gutiérrez, C, et al. Bloodstream infections in cancer patients. Risk factors associated with mortality. Int J Infect Dis 2018;71:59–64.CrossRefGoogle ScholarPubMed
Epstein, L, See, I, Edwards, JR, Magill, SS. Thompson, ND. Mucosal barrier injury laboratory-confirmed bloodstream infections (MBI-LCBI): descriptive analysis of data reported to National Healthcare Safety Network (NHSN), 2013. Infect Control Hosp Epidemiol 2016;31:2–7.CrossRefGoogle Scholar
See, I, Soe, MM, Epstein, L, Edwards, JR, Magil, SS, Thompson, ND. Impact of removing mucosal barrier injury laboratory confirmed bloodstream infections from central-line–associated bloodstream infection rates in the National Healthcare Safety Network, 2014. Am J Infect Control 2016;45:321–323.CrossRefGoogle ScholarPubMed
Kamboj, M, Blair, R, Bell, N, Sun, J, Eagan, J, Sepkowitz, K. What is the source of bloodstream infection due to vancomycin-resistant enterococci in persons with mucosal barrier injury? Infect Control Hosp Epidemiol 2014;35:99–101.CrossRefGoogle ScholarPubMed